Mary Ann Thompson Arildsen, M.D., Ph.D.
- Associate Professor of Pathology, Microbiology and Immunology
Phone
Vanderbilt University Medical Center
4605 TVC (4310)
Nashville, TN 37232
4605 TVC (4310)
Nashville, TN 37232
Mary Ann Thompson Arildsen, M.D., Ph.D.
- Associate Professor of Pathology, Microbiology and Immunology
615-322-3320
maryann.thompson.arildsen@vumc.org
Vanderbilt University Medical Center
4605 TVC (4310)
Nashville, TN 37232
4605 TVC (4310)
Nashville, TN 37232
Research Program
-
Non-Programmatically Aligned
Departments/Affiliations
Profile
Education
- M.D. - University of Pennsylvania, 1983
- Ph.D. - University of Pennsylvania, 1983
- Fellowship - New York University Medical Center
- Internship - NationalCancer Institute of the National Institute of Health
- Post Graduate Training - Institute for Cancer Research
- Post Graduate Training - National Cancer Institute of the National Institute of Health
- Post Graduate Training - Vanderbilt University Medical Center
- Residency - National Institutes of Health
Research Emphasis
Pathogenesis of hematopoietic malignancies
Research Description
Involved in multi-institution project performing comprehensive NGS of hematopoietic malignancies.
Research has focused on changes in microRNA in transformation of follicular lymphoma to DLBCL
Publications
- Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, Eischen CM. MiR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Hum. Pathol [print-electronic]. 2016 Apr; 50: 118-26. PMID: 26997445, PMCID: PMC4804154, PII: S0046-8177(15)00481-5, DOI: 10.1016/j.humpath.2015.11.011, ISSN: 1532-8392.
- Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma. Am. J. Surg. Pathol. 2015 Sep; 39(9): 1250-8. PMID: 25828389, DOI: 10.1097/PAS.0000000000000433, ISSN: 1532-0979.
- Cleveland SM, Goodings C, Tripathi RM, Elliott N, Thompson MA, Guo Y, Shyr Y, Davé UP. LMO2 induces T-cell leukemia with epigenetic deregulation of CD4. Exp. Hematol [print-electronic]. 2014 Jul; 42(7): 581-93.e5. PMID: 24792354, PMCID: PMC4241760, PII: S0301-472X(14)00155-6, DOI: 10.1016/j.exphem.2014.04.010, ISSN: 1873-2399.
- Thompson, M.A.. Wintrobe's Clinical Hematology. 13th Edition. Philadelphia (United States): Lippincott Williams & Wilkins; 2014.Chapter on Molecular Genetics of Acute Leukemia.
- Seegmiller Adam, Thompson Mary Ann. Hematology and Immunology: Quality in Laboratory Diagnosis. New York City (United States): Demos Medical; 2014.95 p.
- Stevens PL, Johnson DB, Thompson MA, Keedy VL, Frangoul HA, Snyder KM. Adult neuroblastoma complicated by increased intracranial pressure: a case report and review of the literature. Case Rep Oncol Med [print-electronic]. 2014; 2014: 341980. PMID: 25328733, PMCID: PMC4190830, DOI: 10.1155/2014/341980, ISSN: 2090-6706.
- Smith S, Tripathi R, Goodings C, Cleveland S, Mathias E, Hardaway JA, Elliott N, Yi Y, Chen X, Downing J, Mullighan C, Swing DA, Tessarollo L, Li L, Love P, Jenkins NA, Copeland NG, Thompson MA, Du Y, Davé UP. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways. PLoS ONE. 2014; 9(1): e85883. PMID: 24465765, PMCID: PMC3897537, PII: PONE-D-13-40599, DOI: 10.1371/journal.pone.0085883, ISSN: 1932-6203.
- Smith MC, Cohen DN, Greig B, Yenamandra A, Vnencak-Jones C, Thompson MA, Kim AS. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. Int J Clin Exp Pathol. 2014; 7(9): 5738-49. PMID: 25337215, PMCID: PMC4203186, ISSN: 1936-2625.
- Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am. J. Clin. Pathol. 2013 Nov; 140(5): 643-50. PMID: 24124142, PMCID: PMC4159763, PII: 140/5/643, DOI: 10.1309/AJCP8CKE9NEINQFL, ISSN: 1943-7722.
- Summers AR, Fischer MA, Stengel KR, Zhao Y, Kaiser JF, Wells CE, Hunt A, Bhaskara S, Luzwick JW, Sampathi S, Chen X, Thompson MA, Cortez D, Hiebert SW. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J. Clin. Invest [print-electronic]. 2013 Jul; 123(7): 3112-23. PMID: 23921131, PMCID: PMC3696547, PII: 60806, DOI: 10.1172/JCI60806, ISSN: 1558-8238.
